Literature DB >> 20096402

Synthesis of acceptor substrate analogs for the study of glycosyltransferases involved in the second step of the biosynthesis of O-antigen repeating units.

John G Riley1, Changchang Xu, Inka Brockhausen.   

Abstract

O-antigens of Gram negative bacteria are polysaccharides covalently attached to lipopolysaccharides (LPS) that have roles as virulence factors. Due to the lack of defined substrates for in vitro assays only a few of the enzymes involved in the biosynthesis of O-antigens have been studied. Many O-antigens have GlcNAc at the reducing end of the oligosaccharide chain linked to pyrophosphate-lipid. We therefore designed and synthesized a series of GlcNAc-pyrophosphate-lipid analogs of the natural GlcNAc-pyrophosphate-undecaprenol acceptor substrate for studies of the acceptor specificities of O-antigen biosynthetic enzymes. We synthesized analogs with modifications of the pyrophosphate bond as well as the lipid chain. These compounds will be useful for the specificity studies of many bacterial glycosyltransferases. Knowledge of the substrate specificities is the basis for the development of specific glycosyltransferase inhibitors that could block O-antigen biosynthesis. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20096402     DOI: 10.1016/j.carres.2009.12.022

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  8 in total

1.  Characterization of two UDP-Gal:GalNAc-diphosphate-lipid β1,3-galactosyltransferases WbwC from Escherichia coli serotypes O104 and O5.

Authors:  Shuo Wang; Diana Czuchry; Bin Liu; Anna N Vinnikova; Yin Gao; Jason Z Vlahakis; Walter A Szarek; Lei Wang; Lu Feng; Inka Brockhausen
Journal:  J Bacteriol       Date:  2014-06-23       Impact factor: 3.490

2.  Biosynthesis of the Common Polysaccharide Antigen of Pseudomonas aeruginosa PAO1: Characterization and Role of GDP-D-Rhamnose:GlcNAc/GalNAc-Diphosphate-Lipid α1,3-D-Rhamnosyltransferase WbpZ.

Authors:  Shuo Wang; Youai Hao; Joseph S Lam; Jason Z Vlahakis; Walter A Szarek; Anna Vinnikova; Vladimir V Veselovsky; Inka Brockhausen
Journal:  J Bacteriol       Date:  2015-04-06       Impact factor: 3.490

3.  Biochemical characterization of UDP-Gal:GlcNAc-pyrophosphate-lipid β-1,4-Galactosyltransferase WfeD, a new enzyme from Shigella boydii type 14 that catalyzes the second step in O-antigen repeating-unit synthesis.

Authors:  Changchang Xu; Bin Liu; Bo Hu; Yanfang Han; Lu Feng; John S Allingham; Walter A Szarek; Lei Wang; Inka Brockhausen
Journal:  J Bacteriol       Date:  2010-11-05       Impact factor: 3.490

Review 4.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

5.  Identification and biochemical characterization of WbwB, a novel UDP-Gal: Neu5Ac-R α1,4-galactosyltransferase from the intestinal pathogen Escherichia coli serotype O104.

Authors:  Diana Czuchry; Walter A Szarek; Inka Brockhausen
Journal:  Glycoconj J       Date:  2017-10-24       Impact factor: 2.916

6.  Chemoenzymatic synthesis of the bacterial polysaccharide repeating unit undecaprenyl pyrophosphate and its analogs.

Authors:  Lei Li; Robert L Woodward; Weiqing Han; Jingyao Qu; Jing Song; Cheng Ma; Peng G Wang
Journal:  Nat Protoc       Date:  2016-06-23       Impact factor: 13.491

7.  Isoprenoid phosphonophosphates as glycosyltransferase acceptor substrates.

Authors:  Mario A Martinez Farias; Virginia A Kincaid; Venkatachalam R Annamalai; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2014-06-10       Impact factor: 15.419

8.  Total Synthesis of an Immunogenic Trehalose Phospholipid from Salmonella Typhi and Elucidation of Its sn-Regiochemistry by Mass Spectrometry.

Authors:  Vivek K Mishra; Jeffrey Buter; Molly S Blevins; Martin D Witte; Ildiko Van Rhijn; D Branch Moody; Jennifer S Brodbelt; Adriaan J Minnaard
Journal:  Org Lett       Date:  2019-06-20       Impact factor: 6.005

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.